Choosing a Research Peptide Supplier in the USA: What to Verify

Almost nothing a peptide supplier says about itself can be checked from the outside. What can be checked is the paperwork, and a handful of specific things in it separate a supplier that measures its material from one that describes it. This is what those things are, grouped by what each one protects you from.

The analysis itself

It has to describe one lot. A certificate of analysis is a record of testing performed on a single production batch, and it should be tied to that batch by photographs of it. A document with no date, no lot identifier and no way of connecting it to the vial in your hand is a brochure with a table in it.

The chromatogram has to be there. A number on its own is an assertion. The trace is what lets you see whether the missing two percent is one large co-eluting impurity or a spread of small ones, and whether the main peak is clean or shouldered. A supplier who shows the trace is inviting you to argue with it, which is exactly what makes the figure worth anything.

Identity has to be established separately. Chromatography shows that the contents are homogeneous. Mass spectrometry shows what the homogeneous thing is. A report giving purity without confirming mass has established a pure unknown. Theoretical and observed mass should appear together.

The wavelength has to be stated. A purity figure measured at 214 nm and one measured at 280 nm are different measurements, and the second under-reports anything lacking aromatic residues. Naming the wavelength is a small thing that tells you the supplier understands what was measured.

Net peptide content decides your arithmetic. It is the figure most often absent. Vial mass includes counter-ion and adsorbed water, so a 10 mg vial commonly holds 7–9 mg of peptide. Without that number your concentrations carry an error nobody has quantified, and any comparison between suppliers is a comparison of packaging. See net peptide content explained.

What the price is actually per

The cheapest listing is often the most expensive material. Two suppliers advertising a 10 mg vial may be selling meaningfully different quantities of compound, and only one of them may be willing to say which. Where net content is published, divide by it and compare price per milligram of peptide. Where it is not published, the comparison is unavailable — which is different from favorable, and should be treated that way.

Whether the material stays the same

A series of experiments is only comparable if the substance is. A supplier that moves through lots quickly without identifying them makes it impossible to know whether the back half of a study used the same material as the front half. One that numbers its lots, publishes analysis per lot and can say which lot is shipping today makes that a question with an answer.

For work spanning months, it is worth asking whether enough of the current lot exists to cover the whole thing, and ordering on that basis rather than on need.

Reading the copy for what is missing

The most reliable signals in this market are absences. A compliant product page has no dosing table, no reconstitution protocol written in units per administration, no testimonials, no before-and-after framing and nothing about how anyone felt. Those gaps are the difference between a research supplier and an unlicensed pharmacy, and a supplier that has blurred the two is carrying a regulatory exposure that turns into your supply problem the day it catches up with them. See the regulatory status of research peptides in the USA.

The same logic applies to handling guidance. A supplier that tells you lyophilized material wants cold storage, that a vial should reach room temperature before it is opened, and that solutions have short usable lives is describing the world. One that implies indefinite stability is selling. See storage and stability.

Where it ships from

Material moving from one US address to another crosses no border, so there is no customs examination, no detention risk and no import charge. An international dispatch introduces all three whatever the listing implies, and the variance it adds is usually worth more than the unit-price difference it saves.

The ten-minute version

• Pick one product and ask for the analysis on the lot currently shipping.
• Check that the batch described can be tied to a physical vial, by printed lot number or by photographs of that batch.
• Look for observed mass next to theoretical mass, and for the detection wavelength next to the purity figure.
• Look for net peptide content. If it is missing, ask — the answer, or the absence of one, is the result.
• Read one product page end to end and see whether any sentence describes an effect in a person.

One product, five questions, and the result generalizes. A supplier that handles all five well is unlikely to be handling everything else badly; one that stumbles on the first has saved you the other four.

What none of it covers

These checks establish that material is what it says it is, at the purity claimed. They do not make an unapproved compound safe or lawful to give to a person, and no supplier document confers that. Research-grade material is not made to pharmaceutical standards and carries no sterility or endotoxin assurance.

Browse the research peptide catalog, or read our guide to reading a certificate of analysis.

All products referenced are supplied for laboratory research use only and are not approved for human consumption, clinical, or veterinary use.

Our own documentation practice and shipping terms are set out in our overview of research peptides across the United States.

Related listings. What that looks like here: the catalog, the published certificates, and bulk ordering for larger quantities.